This study was supported by Medical Research Council (MRC) MR/K015346/1 MATURA study. ARUK 20670 MATURA study. Publisher Copyright: © Author(s) (or their employer(s)) 2019.Objectives We sought to investigate whether genetic effects on response to TNF inhibitors (TNFi) in rheumatoid arthritis (RA) could be localised by considering known genetic susceptibility loci for relevant traits and to evaluate the usefulness of these genetic loci for stratifying drug response. Methods We studied the relation of TNFi response, quantified by change in swollen joint counts (ΔSJC) and erythrocyte sedimentation rate (ΔESR) with locus-specific scores constructed from genome-wide assocation study summary statistics in 2938 genotyped individuals: 37 scores for...
Methotrexate (MTX) monotherapy is a common first treatment for rheumatoid arthritis (RA), but many p...
Background: To prevent debilitating and irreversible joint damage, rheumatoid arthritis (RA) is ofte...
We aimed to validate the association of 28 GWAS-identified genetic variants for response to TNF inhi...
We sought to investigate whether genetic effects on response to TNF inhibitors (TNFi) in rheumatoid ...
Rheumatoid arthritis (RA) is characterised by chronic synovial joint inflammation. Treatment has bee...
Item does not contain fulltextOBJECTIVES: Pharmacogenetic studies of tumour necrosis factor inhibito...
BACKGROUND: Treatment strategies blocking tumour necrosis factor (anti-TNF) have proven very success...
Abstract—In this study, we investigated whether genetic variants known to be related with susceptibi...
agents are successful therapies in rheumatoid arthritis (RA); however, inadequate response occurs in...
Background: Rheumatoid arthritis (RA) is the most frequent autoimmune disease involving the joints. ...
Introduction We aimed to replicate the strong associations that a recent genome wide association st...
Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers that co...
Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers that co...
Anti-tumor necrosis factor alpha (anti-TNF) biologic therapy is a widely used treatment for rheumato...
We aimed to validate the association of 28 GWAS-identified genetic variants for response to TNF inhi...
Methotrexate (MTX) monotherapy is a common first treatment for rheumatoid arthritis (RA), but many p...
Background: To prevent debilitating and irreversible joint damage, rheumatoid arthritis (RA) is ofte...
We aimed to validate the association of 28 GWAS-identified genetic variants for response to TNF inhi...
We sought to investigate whether genetic effects on response to TNF inhibitors (TNFi) in rheumatoid ...
Rheumatoid arthritis (RA) is characterised by chronic synovial joint inflammation. Treatment has bee...
Item does not contain fulltextOBJECTIVES: Pharmacogenetic studies of tumour necrosis factor inhibito...
BACKGROUND: Treatment strategies blocking tumour necrosis factor (anti-TNF) have proven very success...
Abstract—In this study, we investigated whether genetic variants known to be related with susceptibi...
agents are successful therapies in rheumatoid arthritis (RA); however, inadequate response occurs in...
Background: Rheumatoid arthritis (RA) is the most frequent autoimmune disease involving the joints. ...
Introduction We aimed to replicate the strong associations that a recent genome wide association st...
Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers that co...
Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers that co...
Anti-tumor necrosis factor alpha (anti-TNF) biologic therapy is a widely used treatment for rheumato...
We aimed to validate the association of 28 GWAS-identified genetic variants for response to TNF inhi...
Methotrexate (MTX) monotherapy is a common first treatment for rheumatoid arthritis (RA), but many p...
Background: To prevent debilitating and irreversible joint damage, rheumatoid arthritis (RA) is ofte...
We aimed to validate the association of 28 GWAS-identified genetic variants for response to TNF inhi...